- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Arena Pharmaceuticals Inc
+ Add to WatchlistARNA:US
8.0300 USD 0.1100 1.39%As of 12:13:45 ET on 05/23/2013.
Snapshot for Arena Pharmaceuticals Inc (ARNA)
| Open: | 7.8900 | Day's Range: | 7.8400 - 8.0700 | Volume: | 1,982,222 |
|---|---|---|---|---|---|
| Previous Close: | 7.9200 | 52wk Range: | 5.7800 - 13.5000 | 1-Yr Rtn: | +32.31% |
Key Statistics for ARNA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.3800 |
| Est. EPS (USD) (12/2013) | -0.1080 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1,724.79 |
| Shares Outstanding (M) | 217.78 |
| 30 Day Average Volume | 5,279,878 |
| Price/Book (mrq) | 21.7397 |
| Price/Sale (ttm) | 56.4509 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ARNA
Company Profile & Key Executives for ARNA
Arena Pharmaceuticals, Inc. is a biotechnology company that has developed a receptor-based screening assay using their own CART technology.
| Jack LiefChairman/Pres/CEO/Co-Founder | Dominic P BehanExec VP/Chief Scientific Ofcr |
| Steven W SpectorExec VP/General Counsel/Secy | William R Shanahan JrSenior VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ARNA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page